Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 13,172 $ 54,585
Accounts receivable, net 0 1,060
Other receivables 1,919 3,739
Inventory, net 20 38
Prepaid expenses and other current assets 1,290 2,372
Restricted cash, current portion 15 51
Total current assets 16,416 61,845
Property and equipment, net 2,411 2,695
Other long-term asset 0 1,000
Intangible assets, net 0 38
Goodwill 14,409 14,409
Restricted cash, net of current portion 131 227
Total assets 33,367 80,214
Current liabilities:    
Accounts payable 2,882 3,369
Deferred revenue 88 0
Accrued expenses and other current liabilities 13,214 16,519
Notes payable, current 5,930 0
Total current liabilities 22,114 19,888
Notes payable, non-current 13,486 32,833
Royalty obligation 2,000 2,000
Deferred tax liability, net 141 113
Derivative liability 4,830 0
Other long-term liabilities 1,711 2,298
Total liabilities 44,282 57,132
Stockholders’ (deficit) equity:    
Common stock—$0.001 par value; 200,000,000 shares authorized at December 31, 2022 and 2021; 9,430,535 and 9,399,517 shares issued and outstanding at December 31, 2022 and 2021, respectively1 [1] 9 9
Additional paid-in capital1 [1] 292,900 285,239
Accumulated deficit (303,824) (262,166)
Total stockholders’ (deficit) equity (10,915) 23,082
Total liabilities and stockholders’ (deficit) equity $ 33,367 $ 80,214
[1] Amounts for prior periods presented have been retroactively adjusted to reflect the 1-for-12 reverse stock split effected on July 7, 2022. See Note 1 for details.